IP Library Granted Patent US 11,529,630
Granted Patent B2
US 11,529,630 · App. 16/889,256 · Granted Dec 20, 2022

Nanonozzle device arrays: their preparation and use for macromolecular analysis

Inventors: Han Cao (San Diego, CA); Parikshit A. Deshpande (San Diego, CA); Michael David Austin (San Diego, CA); Michael Boyce-Jacino (San Diego, CA)
Assignee: Bionano Genomics, Inc.
B01L3/502761B82Y30/00C12Q1/6869G01N27/447G01N33/48721B01L2200/0663B01L2200/12B01L2300/0645B01L2300/0816B01L2300/0822B01L2300/0896B01L2400/0415B01L2400/0487G01N2035/1039Y10T436/143333Y10T436/2575
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,529,630
App. No.
16/889,256
Granted
Dec 20, 2022
Kind
B2
Abstract

Constricted nanochannel devices suitable for use in analysis of macromolecular structure, including DNA sequencing, are disclosed. Also disclosed are methods for fabricating such devices and for analyzing macromolecules using such devices.

Claims (24)

1. A device for analyzing a polynucleotide macromolecule, the device comprising:

two or more fluid reservoirs joined by a fluid pathway;

a nanochannel having an effective inner diameter between about 10 nm and about 500 nm; and

a discrete constriction in or at a terminal end of the nanochannel, having an effective inner diameter that is no more than about 40% of the effective inner diameter of the nanochannel, wherein the nanochannel and the constriction are located in the fluid pathway between the reservoirs, wherein the constriction is capable of maintaining a linearized polynucleotide macromolecule passing across the constriction in a linearized form,

wherein the device is configured to transport the polynucleotide macromolecule through the nanochannel along a gradient, wherein the device is configured to vary the gradient to pass transport the polynucleotide macromolecule in each of the forward and reverse directions.

2. The device of claim 1 , wherein the device is further configured to vary the gradient to pass a portion of the polynucleotide macromolecule through the constriction multiple times.

3. The device of claim 1 , wherein the gradient is selected from the group consisting of an electroosmotic field, an electrophoretic field, a magnetic field, an electric field, a radioactive field, a mechanical force, an electroosmotic force, an electrophoretic force, an electrokinetic force, a temperature gradient, a pressure gradient, a surface property gradient, a capillary flow, and any combination thereof.

4. The device of claim 1 , wherein the gradient is capable of linearizing at least a portion of the polynucleotide macromolecule residing within at least a portion of the nanochannel.

5. The device of claim 1 , wherein the gradient is capable of transporting at least a portion of the polynucleotide macromolecule located within the nanochannel along at least a portion of the nanochannel.

6. The device of claim 1 , further comprising a sensor associated with the device located to detect a signal from at least a portion of the polynucleotide macromolecule as it passes through the constriction.

7. The device of claim 6 , wherein the sensor is selected from the group consisting of a charge coupled device (CCD) detection system, a complementary metal-oxide semiconductor (CMOS) detection system, a photo diode detection system, a photo-multiplying tube detection system, a scintillation detection system, a photon counting detection system, an electron spin resonance detection system, a fluorescent detection system, a photon detection system, an electrical detection system, a photographic film detection system, a chemiluminescent detection system, an enzyme detection system, an atomic force microscopy (AFM) detection system, a scanning tunneling microscopy (STM) detection system, a scanning electron microscopy (SEM) detection system, an optical detection system, a nuclear magnetic resonance (NMR) detection system, a near field detection system, a total internal reflection (TIRF) detection system, a patch clamp detection system, an electrical current detection system, an electrical amplification detection system, a resistance measurement system, a capacitive detection system, and any combination thereof.

8. The device of claim 6 , wherein the sensor is capable of monitoring one or more locations within one or more of the fluid reservoirs.

9. The device of claim 6 , wherein the sensor is capable of monitoring a location within the nanochannel.

10. The device of claim 6 , wherein the sensor is capable of monitoring a location proximate to an end of the nanochannel.

11. The device of claim 1 , further comprising an illuminator selected from the group consisting of a laser, a source of visible light, a magnet, a source of ultraviolet light, a source of infrared light, and any combination thereof.

12. The device of claim 1 , wherein the nanochannel comprises a length of at least about 50 nm.

13. The device of claim 1 , wherein the constriction resides at an end of the nanochannel.

14. The device of claim 1 , wherein the constriction comprises an effective inner diameter capable of maintaining the linearized polynucleotide macromolecule passing across the constriction in linearized form.

15. The device of claim 1 , wherein the constriction resides within the nanochannel.

16. The device of claim 1 , wherein the nanochannel comprises an effective inner diameter in the range of from about 100 nm to about 300 nm.

17. The device of claim 1 , wherein the nanochannel comprises an effective inner diameter in the range of from about 150 nm to about 250 nm.

18. The device of claim 1 , wherein the constriction comprises an effective inner diameter in the range of from about 10 to about 50 nm.

19. The device of claim 1 , wherein the constriction is configured to locally reduce the effective inner diameter of the nanochannel to be about 0.5 nm to about 100 nm.

20. The device of claim 1 , wherein the constriction is configured to locally reduce the effective inner diameter of the nanochannel to be about 1.5 nm to about 10 nm.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 24, 2024
From: HIGH TRAIL SPECIAL SITUATIONS LLC, AS COLLATERAL AGENT
To: BIONANO GENOMICS, INC.
Reel/Frame 067529/0193 →
SECURITY INTEREST Recorded May 24, 2024
From: BIONANO GENOMICS, INC.; BIODISCOVERY, LLC; LINEAGEN, INC.; PURIGEN BIOSYSTEMS, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 067529/0286 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 16, 2023
From: BIONANO GENOMICS, INC.
To: HIGH TRAIL SPECIAL SITUATIONS LLC
Reel/Frame 065241/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2020
From: CAO, HAN; DESHPANDE, PARIKSHIT A.; AUSTIN, MICHAEL D.; BOYCE-JACINO, MICHAEL
To: BIONANOMATRIX, INC.
Reel/Frame 052805/0018 →
CHANGE OF NAME Recorded Jun 1, 2020
From: BIONANOMATRIX, INC.
To: BIONANO GENOMICS, INC.
Reel/Frame 052805/0687 →
Continuity (7)
Continuation 15801081 · Nov 1, 2017
Continuation 14712816 · May 14, 2015
Division 12374141
Provisional Application 60831772 · Jul 19, 2006
Provisional Application 60908582 · Mar 28, 2007
Provisional Application 60908584 · Mar 28, 2007
Related Publication 20210053823A1 · Feb 25, 2021